{"id":372178,"title":"Final Guidance Document Data Requirements for Safety and Effectiveness of Steroid Nasal Products for Use in the Treatment of Allergic Rhinitis for Industry - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-04-11","captureTimestamp":"2026-04-11T16:16:32.725000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/inhalers/release-final-guidance-document-data-requirements-safety-effectiveness-subsequent-market-entry-steroid-nasal-products-use-treatment-allergic-rhinitis.html","snippet":"Final Guidance Document Data Requirements for Safety and Effectiveness of Steroid Nasal Products for Use in the Treatment of Allergic Rhinitis for Industry (PDF Version - 118 K) Contact: Bureau of Cardiology, Allergy and Neurological Sciences (BCANS) September 19, 2011 Notice Our…","rawSnapshotUrl":"/api/snapshots/raw/372178","browseUrl":"https://replay.healtharchive.ca/job-6/20260411161632/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/inhalers/release-final-guidance-document-data-requirements-safety-effectiveness-subsequent-market-entry-steroid-nasal-products-use-treatment-allergic-rhinitis.html#ha_snapshot=372178","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}